The Searle Company Limited (SEARL) reported a 31 per cent year-on-year increase in consolidated profit for the first quarter of FY27, driven by higher sales and improved margins, according to a research note issued by AKD Securities following the company’s analyst briefing.
The pharmaceutical company posted consolidated earnings of PKR 1.2 billion in 1QFY27 compared with PKR 914 million in the corresponding period last year. Net sales rose 15 per cent year-on-year to PKR 11.2 billion, while gross margins improved by 315 basis points to 57.2 per cent.
According to AKD Securities, the earnings growth was supported by strong topline expansion and margin improvement, reflecting better operational performance during the quarter.
For FY26, however, SEARL’s consolidated earnings declined 34 per cent year-on-year to PKR 536 million, translating into earnings per share of PKR 0.8 against PKR 1.3 in the previous year. The research house attributed the decline primarily to a significantly higher effective tax rate of 87.2 per cent and a one-off goodwill impairment charge of PKR 993 million.
Despite the lower profit, the company recorded a 29 per cent year-on-year increase in revenue to PKR 36.8 billion during FY26, supported by solid demand and improved gross margins, AKD Securities noted.
The management also shared its outlook and strategic priorities during the analyst briefing, expressing confidence in sustaining growth momentum through product expansion and operational efficiencies, according to the brokerage house.